Xaira Therapeutics, a new biotech aiming to “re-engineer” drug discovery and development using artificial intelligence (AI), ...

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming ...

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) in combination with its endocrine therapy Faslodex (fulvestrant) has ...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration aimed at developing CRISPR-based gene ...

Afon Technology has been presented with Junkosha’s Technology Innovator of the Year Award, along with a $25,000 prize, for ...

If you’ve worked in pharma marketing, you’ll know how hard it can be of late. You’ll spend a load of budget on what looks and ...

Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt) has been approved by the US Food and Drug Administration (FDA) to treat ...

Johnson & Johnson’s (J&J) Rybrevant (amivantamab) in combination with chemotherapy, has been recommended by the European ...

Fox&Cat has relaunched today with its new people-first, senior consultant operating model and bespoke planning framework, ...

UCB’s Bimzelx (bimekizumab) has been approved by the European Commission (EC) to treat active moderate-to-severe hidradenitis ...

Up to 40% of patients who have undergone definitive prostate cancer treatment will experience biochemical recurrence within ...